Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 27Recruiting 9Unknown 8Active not recruiting 7Withdrawn 5Terminated 4Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1Carotid Stenosis 1

Interventions

Specimen Handling 32Magnetic Resonance Spectroscopy 21Biopsy 20Cyclophosphamide 16Nivolumab 10Paclitaxel 9Cisplatin 9Gemcitabine 8Bevacizumab 8venetoclax 7Vincristine 7Prednisone 7Doxorubicin 7Azacitidine 7pembrolizumab 6Radiotherapy 6Radiosurgery 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Taxes 5Rituximab 5Oxaliplatin 5Irinotecan 5Everolimus 5Capecitabine 5fludarabine phosphate 4fludarabine 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Interventional × Atorvastatin × Clear all
NCT02022293 2017-12-04

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Suspended
324 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Carotid Stenosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡